AKT1 and breast cancer: In other studies, researchers also investigated the potential effects of ISO on breast cancer and examined the effects of ISO on the AKT/mammalian target of rapamycin (mTOR) and MAPK/MEK signaling cascades, which are two important signaling pathways for endocrine therapy resistance in breast cancer.